Physician profile
Minh Tran
NPI 1457334443
$28,578.38
in general payments reported to CMS, 2019-2025
54 companies · $4,305 in 2025
The $4,305 reported for 2025 was more than what 87% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,316 · 2020: $2,749 · 2021: $3,375 · 2022: $4,021 · 2023: $5,865 · 2024: $4,948 · 2025: $4,305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Travel and Lodging: $701 · Education: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14,306.27 |
| Travel and Lodging | $700.96 |
| Education | $110.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $4,144.18 | 2019-2025 | Tezspire, Fasenra, Airsupra |
| Glaxosmithkline, LLC. | $3,776.67 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Actelion Pharmaceuticals US, INC. | $1,950.26 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Zoll Respicardia, INC. | $1,847.02 | 2020-2025 | Remede System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,505.50 | 2019-2025 | Ofev, Stiolto Respimat, Jascayd |
| Genzyme Corporation | $1,490.29 | 2019-2025 | |
| Grifols USA, LLC | $1,348.31 | 2019-2025 | Prolastin-C Liquid |
| Jazz Pharmaceuticals INC. | $1,092.69 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $1,082.22 | 2019-2025 | Dupixent |
| Philips North America LLC | $941.73 | 2019-2025 | (Ak6) Vest Therapy, Vest Therapy Und, Home Pi Undivided |
| Electromed, INC. | $854.82 | 2021-2025 | Smartvest |
| United Therapeutics Corporation | $785.70 | 2019-2024 | Tyvaso, Orenitram |
| Insmed, INC. | $717.70 | 2019-2025 | Arikayce, Brinsupri |
| Mallinckrodt Hospital Products INC. | $627.71 | 2020-2025 | Acthar |
| Takeda Pharmaceuticals U.S.A., INC. | $581.81 | 2020-2025 | Aralast, Glassia |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $549.11 | 2020-2025 | Wakix |
| Mylan Specialty L.P. | $532.39 | 2019-2024 | Yupelri |
| Ani Pharmaceuticals, INC. | $433.58 | 2023-2025 | Purified Cortrophin Gel |
| Axsome Therapeutics, INC. | $421.22 | 2023-2025 | Sunosi |
| Bayer Healthcare Pharmaceuticals INC. | $419.30 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $343.03 | 2019-2021 | |
| Amgen INC. | $315.28 | 2022-2025 | Tezspire, Tavneos |
| Sunovion Pharmaceuticals INC. | $276.83 | 2019-2021 | |
| Inspire Medical Systems, INC. | $269.25 | 2019-2025 | Inspire |
| Genentech USA, INC. | $244.48 | 2019-2021 | |
| Avadel Cns Pharmaceuticals, LLC | $216.25 | 2024-2025 | Lumryz |
| Intuitive Surgical, INC. | $190.47 | 2022-2025 | |
| Verona Pharma, INC. | $151.10 | 2025 | Ohtuvayre |
| Merck Sharp & Dohme LLC | $127.45 | 2022-2024 | Winrevair |
| Abbvie INC. | $123.78 | 2023 | Rinvoq |
| Shire North American Group INC | $117.83 | 2019 | |
| Boston Scientific Corporation | $115.69 | 2024 | Apollo Esg Nxt System |
| Teva Pharmaceuticals USA, INC. | $115.37 | 2021-2022 | |
| Viatris Specialty LLC | $103.38 | 2025 | Yupelri |
| Tactile Systems Technology INC | $96.79 | 2024-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Circassia INC. | $88.17 | 2019-2020 | |
| Mallinckrodt Enterprises LLC | $58.98 | 2019 | |
| Inogen, INC. | $51.70 | 2020-2025 | |
| 3b Medical, INC. | $48.61 | 2024-2025 | Luna |
| Pulpdent Corporation | $47.73 | 2019 | |
| Alcon Vision LLC | $42.98 | 2022 | |
| Optinose US, INC. | $39.65 | 2025 | |
| Novartis Pharmaceuticals Corporation | $38.17 | 2019 | |
| Idorsia Pharmaceuticals US INC | $37.17 | 2023 | Quviviq |
| Exact Sciences Corporation | $29.12 | 2023 | Cologuard Collection Kit |
| Itamar Medical INC | $26.47 | 2021 | |
| Sanofi-Aventis U.S. LLC | $24.70 | 2021 | |
| Eisai INC. | $22.47 | 2021 | |
| Vapotherm INC | $21.83 | 2022 | |
| Pulmonx Corporation | $21.62 | 2024 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| Paratek Pharmaceuticals, INC. | $19.29 | 2024 | Nuzyra |
| Phadia US INC. | $18.79 | 2021 | |
| Resmed Corp | $17.40 | 2019 | |
| Advanced Respiratory, INC | $14.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Minh Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.